Hyperion Defi (HYPD) Asset Writedowns and Impairment (2023 - 2026)
Hyperion Defi (HYPD) posted quarterly Asset Writedowns and Impairment of $1.2 million for Q1 2026, down 94.11% quarter-over-quarter from $20.9 million in Q4 2025.
Hyperion Defi (HYPD) Asset Writedowns and Impairment (2023 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Asset Writedowns and Impairment for 4 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment changed N/A year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $30.7 million (changed N/A YoY), while the FY2025 annual figure was $27.2 million, up 781.19% from the prior year.
- Asset Writedowns and Impairment slipped to $1.2 million in Q1 2026 per HYPD's latest filing, from $20.9 million in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $20.9 million in Q4 2025 and bottomed at $12218.0 in Q4 2023.
- Historically, Asset Writedowns and Impairment has averaged $3.9 million across 4 years, with a median of $865834.0 in 2024.
- Annual changes were most pronounced in 2024 — Asset Writedowns and Impairment soared 18857.55% — and 2025, when it surged 802.28%.
- Hyperion Defi's Asset Writedowns and Impairment stood at $12218.0 in 2023, then jumped by 18857.55% to $2.3 million in 2024, then soared by 802.28% to $20.9 million in 2025, then slumped by 94.11% to $1.2 million in 2026.
- Business Quant data shows HYPD's Asset Writedowns and Impairment at $1.2 million in Q1 2026, $20.9 million in Q4 2025, and $6.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Hyperion Defi | 44.93 Mn | 35.29 Mn | 357,693.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 800,000.00 |
| Jun 30, 2026 | 800,000.00 |
| Mar 31, 2026 | 1.23 Mn |
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | 20.90 Mn |
| Dec 31, 2025 | 20.90 Mn |
| Sep 30, 2025 | 6.29 Mn |
| Sep 30, 2025 | 6.29 Mn |
| Dec 31, 2024 | 2.32 Mn |
| Dec 31, 2024 | 2.32 Mn |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 85,051.00 |
| Mar 31, 2024 | 85,051.00 |
| Dec 31, 2023 | 12,218.00 |
| Dec 31, 2023 | 12,218.00 |